Guido Magni

Direktor/Vorstandsmitglied bei

Anabasis SRL

72 Jahre

86 Beziehungen

Health Technology

Consumer Services

Finance

Profil

Guido Magni currently works at Biotie Therapies AG, as Director, Anabasis SRL, as Director, Nouscom AG, as Director from 2020, Nouscom Srl, as Director, and AM-Pharma Holding BV, as Member-Supervisory Board.
Dr. Magni also formerly worked at Adolor Corp., as Independent Director, Biotie Therapies Oy, as Independent Director, Aprea Therapeutics AB, as Director from 2016 to 2020, Versant EuroVentures, as Managing Director, Tarveda Therapeutics, Inc., as Director, Gensight Biologics SA, as Director from 2013 to 2019, PIQUR Therapeutics AG, as Director, Mosaic Biomedicals SL, as Director, LAVA Therapeutics NV, as Non-Executive Director from 2021 to 2023, Aprea Therapeutics, Inc., as Independent Director from 2016 to 2020, Roche Holding AG, as Head-Medical Science & Global Drug Development, Synosia Therapeutics AG, as Member-Management Board, Hoffmann-La Roche, Inc., as Global Head-Medical Science Division in 2008, Aravis AG, as Managing Partner from 2011 to 2013, AM-Pharma BV, as Member-Supervisory Board, and Versant Ventures (Switzerland) GmbH, as Partner.
Dr. Magni received his doctorate degree in 1981 from The American University of Rome and doctorate degree in 1977 from the University of Padua.

Aktive Positionen von Guido Magni

Unternehmen	Position	Beginn
Anabasis SRL Anabasis SRL Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research and development services	Direktor/Vorstandsmitglied	-
AM-Pharma Holding BV AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology Engages in financial investment and shareholding activities	Direktor/Vorstandsmitglied	-
Nouscom AG Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies	Direktor/Vorstandsmitglied	11.12.2020
Biotie Therapies AG Biotie Therapies AG Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in developing drugs for the treatment of psychiatry and neurology diseases	Direktor/Vorstandsmitglied	-
Nouscom Srl Nouscom Srl Miscellaneous Commercial ServicesCommercial Services Operates as a next-generation immunotherapy company that develops engineered viral vectored vaccines for treatment of cancer	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Guido Magni

Ehemalige bekannte Positionen von Guido Magni

Unternehmen	Position	Ende
LAVA THERAPEUTICS N.V.	Direktor/Vorstandsmitglied	01.01.2023
Aprea Therapeutics AB Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds	Direktor/Vorstandsmitglied	30.06.2020
APREA THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	30.06.2020
GENSIGHT BIOLOGICS S.A.	Direktor/Vorstandsmitglied	24.04.2019
░░░░░░ ░░░░░░░░░░░ ░░	░░░░░░░░░░░░░░░░░░░░░░░░░░	░░░░░░░░░░

Sehen Sie sich die Erfahrung von Guido Magni im Detail an

Ausbildung von Guido Magni

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Guido Magni im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	23
Roche Holding AG Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics	Health Technology
Adolor Corp. Adolor Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company	Health Technology
The American University of Rome The American University of Rome Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Synosia Therapeutics AG Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of psychiatry and neurology diseases	Health Technology
Biotie Therapies AG Biotie Therapies AG Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in developing drugs for the treatment of psychiatry and neurology diseases	Health Technology
Biotie Therapies Oy Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products	Health Technology
Hoffmann-La Roche, Inc. Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions	Health Technology
University of Padua University of Padua Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AM-Pharma Holding BV AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology Engages in financial investment and shareholding activities	Health Technology
Aravis AG Aravis AG Investment ManagersFinance Aravis is a hands-on investment partner. They work closely with their portfolio firms while providing capital and access to their international network of professionals. The firm's investment strategy targets early-stage firms active in biopharmaceutical, medical technology and biotechnology sectors in Europe, North America and Asia. They have a particular focus on cross-border deals and in firms operating in immunology, inflammation, oncology and CNS segments. They also invest in renewable energy businesses in Europe where they believe there are substantial growth opportunities. They concentrate on firms in the development phase which employ mature established energy production technologies, namely wind, hydroelectric or photovoltaic cells. Aravis has experience initiating, financing and structuring complex projects. The firm aims to diligently conduct scientific and technical analysis of potential projects prior to capital commitment. They look for firms which display optimal risk/return profiles. They closely monitor the quality of the science and actively continue with hands-on intervention in challenging situations, aiming to create value through deal structuring in parallel with careful entry valuations.	Finance
Aprea Therapeutics AB Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds	Health Technology
AM-Pharma BV AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products	Health Technology
Versant EuroVentures
Tarveda Therapeutics, Inc. Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs	Health Technology
Anabasis SRL Anabasis SRL Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research and development services	Commercial Services
Gensight Biologics SA Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases	Health Technology
PIQUR Therapeutics AG PIQUR Therapeutics AG Pharmaceuticals: MajorHealth Technology Engages in discovery and development of anti-cancer drugs	Health Technology
Mosaic Biomedicals SL Mosaic Biomedicals SL Hospital/Nursing ManagementHealth Services Develops personalized cancer treatments	Health Services
Nouscom AG Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies	Health Technology
Versant Ventures (Switzerland) GmbH Versant Ventures (Switzerland) GmbH Investment ManagersFinance Acts as an alternative investment manager	Finance
LAVA Therapeutics NV LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer	Health Technology
Aprea Therapeutics, Inc. Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds	Health Technology
Nouscom Srl Nouscom Srl Miscellaneous Commercial ServicesCommercial Services Operates as a next-generation immunotherapy company that develops engineered viral vectored vaccines for treatment of cancer	Commercial Services